stars 1 stars 2 stars 3

Altea Therapeutics has made a key scientific and commercial breakthrough in the delivery of drugs and vaccines via the skin. The PassPort® patch, a cost-effective and easy to use skin patch, uses short bursts of focused thermal energy to create hundreds of tiny channels in the surface of the skin. These channels permit the rapid and sustained flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. Altea Therapeutics is a privately-held company, with Domain Associates, Venrock Associates, vSpring Capital, KBC Investco, Aperture Venture Partners, Quilvest, CX BioVentures, and Rockport Venture Partners as primary investors. Our intellectual property portfolio includes over 30 issued patents (U.S. and foreign) and provides comprehensive protection for our pipeline products to at least 2020.

View Top Employees from Altea Therapeutics

Altea Therapeutics Questions

The Altea Therapeutics annual revenue was $21.3 million in 2023.

Loren Lantz is the Director, Engineering of Altea Therapeutics.

8 people are employed at Altea Therapeutics.

Altea Therapeutics is based in Atlanta, Georgia.

The NAICS codes for Altea Therapeutics are [54171, 325, 541711, 54, 33, 32, 5417, 541].

The SIC codes for Altea Therapeutics are [28, 80, 283].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users